Publications by authors named "J M Saugar"
Article Synopsis
- Pet dogs and cats provide health benefits to their owners but can spread zoonotic infections if not properly cared for.
- A study in Spain found that nearly half of the sampled dogs (48.8%) and cats (48.6%) were infected with intestinal parasites, with Giardia duodenalis being common in dogs and several species affecting cats.
- The research emphasizes the importance of hygiene, regular veterinary care to prevent infections, and warns vulnerable populations against interacting with symptomatic puppies and kittens.
Prevalence of Strongyloides stercoralis infection and associated clinical symptoms among schoolchildren living in different altitudes of Amhara National Regional State, northwest Ethiopia.
PLoS Negl Trop Dis
April 2022
Article Synopsis
- * A study of 844 schoolchildren in Amhara Region was conducted using multiple diagnostic techniques to determine the prevalence of S. stercoralis and other soil-transmitted helminths; the infection rates showed significant variation based on age, sex, and rural versus urban dwelling.
- * The prevalence of S. stercoralis was found to be 39% when using various diagnostic methods, with higher rates in males, rural areas, and children aged 12-14; symptoms like abdominal pain, cough
Background: Strongyloides stercoralis is an intestinal parasite that can cause chronic infection, hyperinfection and/or a dissemination syndrome in humans. The use of techniques targeting ova fails to detect S. stercoralis, as only larvae of the parasite are excreted in faeces.
View Article and Find Full Text PDFBackground: The main aims of this study were to analyze trends of SARS-CoV-2 anti-nucleocapsid IgG throughout the four rounds of the seroepidemiologic study ENE-COVID, and compare the fourth-round results of two immunoassays detecting anti-nucleocapsid and anti-RBD IgG.
Methods: ENE-COVID was developed in 2020 (two phases). Phase one included three rounds carried out in April 27-May 11, May 18-June 1, and June 8-June 22.
Strongyloidiasis affects an estimated 600 million people worldwide, especially in tropical and subtropical areas. Single-dose ivermectin treatment has shown to be effective among immunocompetent patients with uncomplicated strongyloidiasis. Here, we present the protocol of the ImmunoStrong study, a prospective observational study aiming to evaluate the effectiveness and safety of a single-dose ivermectin for treatment of uncomplicated strongyloidiasis in immunosuppressed patients.
View Article and Find Full Text PDF